- VietPharmaTech 2026 / The International Exhibition on Analytical and Laboratory Equipment in Vietnam - VietLab Expo 2024 from November 21 - 23, 2026 at Saigon Exhibition & Convention Center (SECC). Vietnam Medical Devices Association highly...
result." When Revenue Grows as Drug Spending Rises National prescription drug spending increased 7.9% to $467 billion in 2024 after growing 10.8% the previous year, according to the Centers for Medicare & Medicaid Services (CMS). Retail...
oncology. Scrip 100 positions Glenmark among the Top 100 biopharmaceutical companies globally by pharmaceutical sales for 2024. For more information, please visit www.glenmarkpharma.com.
marrow failure. According to the Chinese Guideline for the Diagnosis and Treatment of Paroxysmal Nocturnal Hemoglobinuria (2024 Edition), treatment of PNH should be based on clinical subtype, and complement inhibitors are recommended as first-line...
and Ono Pharmaceutical. The combination of cetuximab, encorafenib and FOLFOX received accelerated FDA approval in December 2024 for treatment-naïve patients based on ORR data, and full FDA approval in February 2026 based on PFS and OS data — with...
Titan XT automated dispensing system and expansion of the cloud-native OmniSphere platform. “Since joining Omnicell in 2024, Nnamdi has made a significant strategic impact on the Company, working to strengthen our operational foundation, shape our...
WISE's investor base as a strategic partner. This final closing builds on the first closing of the round completed in June 2024, which included a venture debt facility from the European Investment Bank (EIB) supported by InvestEU, alongside an...
strains from Lallemand to support digestive and immune health during the critical early-life period. Since its founding in 2024, NurtureBio works with leading breast milk and microbiome researchers to translate emerging science into accessible...
with a central laboratory-confirmed negative SARS-CoV-2 test at baseline. The trial was conducted from June 2023–September 2024. More than 99% of household contacts tested positive for antibodies against SARS-CoV-2 N (nucleocapsid) or S (spike)...
and Kincell Bio, as well as other leading CDMOs and two Tier 1 pharma companies. Since its commercial launch in December 2024, IRO® has been adopted across R&D, PD and now clinical settings. Ori expects the first INDs for IRO®-manufactured products...
care expenditures." MinuteClinic can also serve as a primary care provider to eligible patients 18 and older. Launched in 2024 and continuing to expand across the U.S., MinuteClinic Primary Care enables providers to identify and manage related...
patients are appropriately identified for targeted therapy." BIZENGRI was first approved under accelerated approval in 2024 in advanced, unresectable or metastatic non-small cell lung cancer and pancreatic adenocarcinoma for patients harboring an...
(HMOs) and targeted probiotic strains to support digestive and immune health in infants and toddlers. Founded in 2024 by Stuart Smith, a parent motivated by firsthand experience, the company collaborates with leading breast milk and microbiome...
by targeting different B-cell protein targets, as well as evaluating different depths of B-cell depletion. Established in 2024 and headquartered in San Diego, CA, Candid is led by a team of entrepreneurial executives who have a track record of...
CK0801 Phase 1 Trial Outcomes Phase 1 results for CK0801 in bone marrow failure syndromes were published in NEJM Evidence (2024). In that study of 9 enrolled patients (4 with aplastic anemia, 4 with myelofibrosis, and 1 with hypoplastic...
from the CAHtalyst Phase 3 studies supported approval of CRENESSITY by the U.S. Food and Drug Administration in December 2024. The open-label extension treatment portions of both studies are ongoing. Important Information Approved Uses CRENESSITY®...
including Parkinson’s disease and multiple sclerosis. Merz Therapeutics acquired the company's commercial portfolio in 2024. Previously, Dr. Cohen was a principal in the startup and an officer of Advanced Tissue Sciences, Inc., a biotechnology...
and its scientific partners, in which multiple FcγR genes were humanized. Since its launch to the scientific community in 2024, genO-hFcγR has been adopted to advance preclinical programs of biopharmaceutical companies and nonprofit organizations,...
subsequent global regulatory approvals. Interim data from RSV season 1 of the SMART trial were also presented at IDWeek 2024 and published in the New England Journal of Medicine. The SMART trial enrolled infants at increased risk of severe RSV...
treatment options by providing high consistency in drug exposure and a convenient method of administration.2,3 In July 2024, CT-P13 SC received final approval from the European Commission for an additional dosing regimen and dose escalation, which...
